Prevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanisms.

[1]  A. Mohamadin,et al.  Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic Rats , 2011, Journal of lipids.

[2]  B. Aggarwal,et al.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach. , 2011, Current drug targets.

[3]  A. Alghadyan,et al.  Diabetic retinopathy - An update. , 2011, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[4]  H. Al‐Mezaine,et al.  Advances in the treatment of diabetic retinopathy. , 2011, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[5]  S. Govoni,et al.  The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. , 2010, Biochemical pharmacology.

[6]  Jiaweng Fan,et al.  ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina. , 2010, Investigative ophthalmology & visual science.

[7]  E. Leal,et al.  High glucose and interleukin-1beta downregulate interleukin-1 type I receptor (IL-1RI) in retinal endothelial cells by enhancing its degradation by a lysosome-dependent mechanism. , 2010, Cytokine.

[8]  R. Kowluru,et al.  Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2. , 2009, Free radical biology & medicine.

[9]  E. Agardh,et al.  TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. , 2008, Journal of diabetes and its complications.

[10]  G Thippeswamy,et al.  Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-B and its DNA binding activity. , 2008, European journal of pharmacology.

[11]  D. Graves,et al.  Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. , 2008, The American journal of pathology.

[12]  P. Dodson,et al.  PKC inhibition and diabetic microvascular complications. , 2007, Best practice & research. Clinical endocrinology & metabolism.

[13]  A. Supe,et al.  Immunomodulatory role of Tinospora cordifolia as an adjuvant in surgical treatment of diabetic foot ulcers: a prospective randomized controlled study. , 2007, Indian journal of medical sciences.

[14]  G. King,et al.  The role of protein kinase C activation and the vascular complications of diabetes. , 2007, Pharmacological research.

[15]  S. Sizmaz,et al.  Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy , 2006, Eye.

[16]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[17]  Nisha Singh,et al.  Effect of Tinospora Cordifolia on the Antitumor Activity of Tumor-Associated Macrophages–Derived Dendritic Cells , 2005, Immunopharmacology and immunotoxicology.

[18]  R. Kowluru,et al.  Role of interleukin-1β in the pathogenesis of diabetic retinopathy , 2004, British Journal of Ophthalmology.

[19]  V. Menon,et al.  Restoration of antioxidant defence by ethanolic Tinospora cordifolia root extract in alloxan‐induced diabetic liver and kidney , 2004, Phytotherapy research : PTR.

[20]  J. P. Singh,et al.  Tinospora cordifolia (Guduchi), a reservoir plant for therapeutic applications: A Review , 2004 .

[21]  V. Menon,et al.  Restoration of antioxidants by ethanolic Tinospora cordifolia in alloxan-induced diabetic Wistar rats. , 2004, Acta poloniae pharmaceutica.

[22]  Ronald Klein,et al.  The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. , 2004, Archives of ophthalmology.

[23]  V. Menon,et al.  Hypoglycaemic and hypolipidaemic action of alcohol extract of Tinospora cordifolia roots in chemical induced diabetes in rats , 2003, Phytotherapy research : PTR.

[24]  Anil C. Ghosh,et al.  Chemistry and medicinal properties of tinospora cordifolia (GUDUCHI) , 2003 .

[25]  N. Biswas,et al.  Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts , 2002, Phytotherapy research : PTR.

[26]  Soumya Ghosh,et al.  Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats. , 2002, The Journal of toxicological sciences.

[27]  M. Subramanian,et al.  Antioxidant properties of a Tinospora cordifolia polysaccharide against iron-mediated lipid damage and γ-ray induced protein damage , 2002, Redox report : communications in free radical research.

[28]  H. Goel,et al.  Free radical scavenging and metal chelation by Tinospora cordifolia, a possible role in radioprotection. , 2002, Indian journal of experimental biology.

[29]  J. Grover,et al.  Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. , 2000, Journal of ethnopharmacology.

[30]  L. Aiello,et al.  Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.

[31]  V. Menon,et al.  Hypoglycaemic and other related actions of Tinospora cordifolia roots in alloxan-induced diabetic rats. , 2000, Journal of ethnopharmacology.

[32]  S. Bursell,et al.  Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? , 1999, Diabetes research and clinical practice.

[33]  L. Aiello,et al.  High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. , 1999, Diabetes care.

[34]  V. Menon,et al.  Antioxidant activity of Tinospora cordifolia roots in experimental diabetes. , 1999, Journal of ethnopharmacology.

[35]  H. Suzuki,et al.  Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes , 1997, Diabetologia.

[36]  L. Aiello,et al.  Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. , 1997, Diabetes/metabolism reviews.

[37]  L. Aiello,et al.  Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. , 1996, The Journal of clinical investigation.

[38]  G. A. Limb,et al.  Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. , 1996, The British journal of ophthalmology.

[39]  A. Cerami,et al.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.

[40]  P. Daisy,et al.  Anti-diabetic properties of Tinospora cordifolia stem extracts on streptozotocin-induced diabetic rats. , 2009 .

[41]  S. Biswas,et al.  Bmc Complementary and Alternative Medicine Rubia Cordifolia, Fagonia Cretica Linn and Tinospora Cordifolia Exert Neuroprotection by Modulating the Antioxidant System in Rat Hippocampal Slices Subjected to Oxygen Glucose Deprivation , 2004 .

[42]  G. Kuttan,et al.  Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals. , 2004, International immunopharmacology.

[43]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.